Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: N06AX21

Duloxetine Zentiva(duloxetine)

Neuralgia;Depressive Disorder, Major;Anxiety Disorders;Diabetes Mellitus

Marketing Authorisation Holder: Zentiva, k.s.

EMA Authorisation: 20/08/2015

INN: duloxetine

Indication

Treatment depressive disorder, diabetic neuropathic pain, anxiety disorder. Duloxetine Zentiva is indicated in adults.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Duloxetine Zentiva — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.